Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Compass Therapeutics, Inc. (CMPX) had Operating Cash Flow per Share of $-0.09 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-18.32M |
|
-- |
|
-- |
|
$20.30M |
|
$-20.30M |
|
$1.98M |
|
$-18.32M |
|
$-18.32M |
|
$-18.32M |
|
$-18.32M |
|
$-18.32M |
|
$-18.32M |
|
$-20.30M |
|
$-20.14M |
|
186.40M |
|
186.40M |
|
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$195.69M |
|
$0.17M |
|
$9.48M |
|
$205.17M |
|
$10.28M |
|
-- |
|
$8.42M |
|
$18.70M |
|
$186.47M |
|
$186.47M |
|
$186.47M |
|
180.09M |
|
| Cash Flow Statement Financials | |
$-17.27M |
|
$38.43M |
|
$3.37M |
|
$31.21M |
|
$55.74M |
|
$24.52M |
|
$5.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.82% |
|
-9.82% |
|
-8.93% |
|
-9.82% |
|
$1.04 |
|
$-0.09 |
|
|
Operating Cash Flow per Share |
$-0.09 |